USFDA Approves Sanofi’s ‘Taxotere’ For Head, Neck Cancer

Paris: Sanofi-Aventis, French pharmaceutical group has annunciated that the U.S. health officials have approved another application of its anti-cancer drug ‘Taxotere.’

The company said that the drug has been sanctioned to treat locally advanced head and neck cancer before chemo-radiotherapy and surgical treatment.

The approval is based on the outcomes of a phase III clinical examination, which showed that adding up Taxotere to typical induction chemotherapy resulted in a more than three year betterment in patient endurance rate.

NASA/ESA Solar observatory finds its first officially periodic comet

Paris, Sept 26 : The ESA/NASA Solar and Heliospheric Observatory (SOHO) has discovered its first officially periodic comet - which flies by the Sun at regular intervals. SOHO had already spotted this comet twice before.

The find is important, as this is the first one conclusively proven and officially declared by SOHO as a periodic comet.